DISEASE SCANNER
Global Incurable Diseases Tracker
Irritable Bowel Syndrome (IBS)
A common functional gastrointestinal disorder affecting the large intestine, characterized by abdominal pain and altered bowel habits (diarrhea, constipation, or both). Brain-gut interaction disorder without structural abnormalities. Affects 10-15% of global population.
780.0M
111
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Rome IV criteria
- 2Exclusion of organic disease
- 3Stool studies
- 4Blood tests
- 5Colonoscopy (alarm features)
- 6Lactose/fructose breath testing
- 7Fecal calprotectin
Prognosis
Chronic condition with fluctuating course. Symptoms improve in 30-40% over time. Quality of life significantly impacted. Not associated with increased mortality or cancer risk.
Prevention
- Stress management
- Regular exercise
- Healthy diet
- Adequate sleep
- Probiotics (possibly)
- Avoiding trigger foods
Research Status
Low-FODMAP diet effective. Gut-directed hypnotherapy showing promise. Guanylate cyclase-C agonists (linaclotide, plecanatide) for IBS-C. Rifaximin for IBS-D. Eluxadoline (mixed opioid agonist) for IBS-D. Microbiome modulation research. Brain-gut behavioral therapies expanding.
Affected Countries
Sources
- https://www.cdc.gov/
- https://www.ncbi.nlm.nih.gov/books
- https://www.mayoclinic.org/diseases-conditions
- https://www.crohnscolitisfoundation.org
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.